Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

HIV breakthrough as trial vaccine cuts risk of infection

  • Comment

HIV researchers have made a major breakthrough with the discovery of a vaccine that can significantly reduce the risk of infection

The HIV vaccine is a combination of two earlier vaccines which had proved ineffective.

In a study carried out by the US Army and the Thai government, the largest of its kind, the vaccine was given to 16,000 people in Thailand.

Half of the volunteers were given the vaccine, while the other half were given a placebo. The researchers were keen to stress that all participants were given counselling on HIV/Aids prevention. They were then tested for HIV infection every six months for three years.

The rate of HIV infection in those who had taken the vaccine was 31.2% less than those given placebo, with 74 people who did not get the vaccine infected and 51 of the vaccinated group infected.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.